# FDA Inspection 1206602 - David M. Rosmarin, M.D - May 16, 2023

Source: https://www.keypedia.com/records/fda_inspections/david-m-rosmarin-md/2074ff15-7893-4afa-9b13-590ebeb6b35b
Source feed: FDA_Inspections

> FDA Inspection 1206602 for David M. Rosmarin, M.D on May 16, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1206602
- Company Name: David M. Rosmarin, M.D
- Inspection Date: 2023-05-16
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

Company: https://www.keypedia.com/companies/david-m-rosmarin-md/35f40efa-1087-4aec-b88f-2b31911358ca

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c